ACE inhibitors not worth it as first-line therapy in hypertension

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.413, 2003-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE inhibitors not worth it as first-line therapy in hypertension

By  

Inpharma, Vol. 1, Iss. 1388, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of ACE Inhibitors as First-Line Antihypertensive Therapy

By Nordmann A.J.   Krahn M.   Logan A.G.   Naglie G.   Detsky A.S.  

PharmacoEconomics, Vol. 21, Iss. 8, 2003-01 ,pp. : 573-585

Adis International

Access to resources Recommend Favorite

Spironolactone "safer first-line" therapy for hypertension

By  

Reactions Weekly, Vol. 1, Iss. 1254, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

-Blockers: "not appropriate" first-line therapy for hypertension

By  

Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Combination Therapy as First-Line Treatment for Hypertension

By Crawford Michael H.  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 1, 2009-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite